Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

Item

http://www.wikidata.org/entity/Q34323973

Q34323973

about

Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy The role of inflammation in schizophrenia Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment The neuroimmunology of schizophrenia Glutamatergic autoencephalitides: an emerging field Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms Autoimmune encephalitis in psychiatric institutions: current perspectives The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.Current and emergent treatments for symptoms and neurocognitive impairment in schizophrenia.Autoimmune encephalopathies.Inflammation and the two-hit hypothesis of schizophrenia.Neurology issues in schizophrenia.Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies.Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters.Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges.Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis.Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?Progressive limbic encephalopathy: Problems and prospects.The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond.Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization.Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis.The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.Neuronal surface antibody-mediated autoimmune encephalitis.Case report: low-titre anti-Yo reactivity in a female patient with psychotic syndrome and frontoparieto-cerebellar atrophy.Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatment Fact or fiction? Examining a role for N-methyl-D-aspartate receptor autoantibodies in psychiatric illness.Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients.Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.Autoantibodies against the N-Methyl-d-Aspartate Receptor Subunit NR1: Untangling Apparent Inconsistencies for Clinical Practice.Is there a role for immune-to-brain communication in schizophrenia?Autoimmune Encephalitis in Postpartum Psychosis.

P2860

Q26746048-CC7CA4F3-7C34-42E1-8AFA-948ED2DA7FEC Q26774472-DC6F4C60-CFAD-43B1-9BB5-CB4A2F3B8055 Q26779719-5D224BB5-6C8D-4B59-A03F-93D23425273C Q26781620-AC9D6D52-0B21-4E2A-A7E5-638C38255708 Q26801897-5727483D-514F-448E-8DB4-24B48D538DE9 Q26859392-1108A0DB-C227-416E-9E07-2D41B0318F14 Q26992294-B01084FB-83FA-4895-987B-4E66B77B1446 Q27006941-938660A8-3B53-4AC0-9EF0-5CF47B31376F Q28079666-D890939E-CAA1-4E7D-BFD8-0BA1A8B8DD78 Q30362017-0E81717B-BCA5-40EE-9DC5-919E1D23A614 Q30382281-745916D0-DF2C-405E-BB9B-C98554EE19C6 Q30389491-BA24A8E5-A37F-492E-822E-91744EAA5134 Q30422062-E2B6245E-4A50-48D3-BA5C-81D30B21DB2F Q30910367-1498AFD2-C1E5-4E1D-B74C-A443D0C63C4C Q33551430-976708C1-F980-4329-AB39-E74F57600A45 Q33577793-40FF5AAB-8C76-4929-A516-1B530F101F89 Q33610959-A5C7CE16-719E-4C99-A05C-EA57D83B130D Q33740560-98CA6B6C-F74E-43B0-8A2B-0282B57DF808 Q33857841-B8EA4020-7568-4C72-9552-8243DBDA858B Q33862239-E9BD5056-3844-4E67-8946-87482C278456 Q33871737-4F9878DE-57BA-4A03-9F98-2494920C703D Q33877818-24E1E52E-712B-4676-A3F8-EF8D953E8046 Q33920257-09A32C36-3520-4AAE-BFAF-895962D247E3 Q34323034-56F1F1DA-7359-4ED6-8557-D16DE660D447 Q34348224-46727A2F-6424-46EE-B3A6-9AEFC30C5D0A Q34428194-1B6E7A35-992C-4C4E-8AED-AB8D79DA0528 Q34455707-9B8D890A-C4ED-40B0-AAC8-50B5999C5A44 Q34460610-CEA9AB55-2C5C-4076-86CE-33AA38F7D148 Q34669114-A5BDFE5D-CB1E-478F-A698-65CA1A896565 Q35035280-4AC95FA6-2FCF-4780-A75B-41465F32965E Q35382798-ED51ECC8-BA38-41DD-8F78-520DD0C5D06B Q35392781-B636CBC7-3930-40B3-A51E-44BE2A57F748 Q35620255-4A6E4D7F-1727-403A-AAB4-18876F3E823C Q35746924-07AB466A-15F3-48EE-B54F-95958DEE803F Q35770227-E6E770D2-8BB1-4C89-8091-14C59C0D04D8 Q36043407-AB57ACDF-012D-4230-805A-711A03B9C8F0 Q36071538-04242F27-0D82-4D7C-A8A4-B5212338F561 Q36309804-B43B2467-D7A5-4481-B06A-26A436900BF3 Q36351021-15C0ECEE-7605-4E17-8BFE-A7800F5632DC Q36862598-B27D8F3F-FBAE-4E90-8A47-5F8446C9C45F

P2860

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

Item

http://www.wikidata.org/entity/Q34323973

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu